Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new type of coronavirus causing coronavirus 2019 (COVID-19) that was first observed in Wuhan, China, in Dec. 2019. An inflammatory immune response targeting children appeared during the pandemic, which was associated with COVID-19 nam...

Descripción completa

Detalles Bibliográficos
Autores principales: Suksatan, Wanich, Chupradit, Supat, Yumashev, Alexei Valerievich, Ravali, Sahithya, Shalaby, Mohammed Nader, Mustafa, Yasser Fakri, Kurochkin, Anatoley, Siahmansouri, Homayoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487784/
https://www.ncbi.nlm.nih.gov/pubmed/34627083
http://dx.doi.org/10.1016/j.intimp.2021.108217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487784/
https://www.ncbi.nlm.nih.gov/pubmed/34627083
http://dx.doi.org/10.1016/j.intimp.2021.108217

Ejemplares similares